作者
JAN Hoyer, Ines Neundorf
发表日期
2012/7/17
来源
Accounts of chemical research
卷号
45
期号
7
页码范围
1048-1056
出版商
American Chemical Society
简介
Over the past two decades, gene therapy has garnered tremendous attention and is heralded by many as the ultimate cure to treat diseases such as cancer, viral infections, and inherited genetic disorders. However, the therapeutic applications of nucleic acids extend beyond the delivery of double-stranded DNA and subsequent expression of deficient gene products in diseased tissue. Other strategies include antisense oligonucleotides and most notably RNA interference (RNAi). Antisense strategies bear great potential for the treatment of diseases that are caused by misspliced mRNA, and RNAi is a universal and extraordinarily efficient tool to knock down the expression of virtually any gene by specific degradation of the desired target mRNA.
However, because of the hurdles associated with effective delivery of nucleic acids across a cell membrane, the initial euphoria surrounding siRNA therapy soon subsided …
引用总数
201220132014201520162017201820192020202120222023202452830231912132020919166
学术搜索中的文章